Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

CV Sciences (CVSI) Shares Outstanding (2016 - 2025)

CV Sciences' Shares Outstanding history spans 15 years, with the latest figure at $184.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $184.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $184.3 million, a 0.0% change, with the full-year FY2025 number at $184.3 million, changed 0.0% from a year prior.
  • Shares Outstanding hit $184.3 million in Q4 2025 for CV Sciences, roughly flat from $184.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CVSI hit a ceiling of $184.3 million in Q3 2024 and a floor of $1000.0 in Q1 2022.
  • Historically, Shares Outstanding has averaged $149.4 million across 5 years, with a median of $158.1 million in 2023.
  • Biggest five-year swings in Shares Outstanding: tumbled 100.0% in 2022 and later surged 15210300.0% in 2023.
  • Tracing CVSI's Shares Outstanding over 5 years: stood at $112.5 million in 2021, then soared by 35.23% to $152.1 million in 2022, then grew by 6.29% to $161.7 million in 2023, then grew by 13.97% to $184.3 million in 2024, then changed by 0.0% to $184.3 million in 2025.
  • Business Quant data shows Shares Outstanding for CVSI at $184.3 million in Q4 2025, $184.3 million in Q3 2025, and $184.3 million in Q2 2025.